Meeting
2016 ASCO Annual Meeting
Estimation of 10-year (y) cardiovascular disease (CVD) risk after cisplatin-based chemotherapy (CBCT): A multi-institutional study of 459 germ cell tumor (GCT) survivors in the Platinum study.
Authors
Darren R. Feldman
Memorial Sloan Kettering Cancer Center, New York, NY
Darren R. Feldman , Shirin Ardeshir-Rouhani-Fard , Patrick Monahan , Chunkit Fung , Robert James Hamilton , David J. Vaughn , Clair Beard , Kevin C. Oeffinger , Lawrence H. Einhorn , Sophie D. Fossa , Howard D. Sesso , Lois B. Travis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Survivorship
Citation
J Clin Oncol 34, 2016 (suppl; abstr 10083)
DOI
10.1200/JCO.2016.34.15_suppl.10083
Abstract #
10083
Poster Bd #
71
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Effect of pretreatment central adiposity on the cardiometabolic risk of male germ cell tumor survivors after cisplatin-based chemotherapy.
First Author: Andreas Georg Wibmer
Poster
2024 ASCO Genitourinary Cancers Symposium
Longitudinal assessment of cognitive functioning in testicular germ cell tumor survivors.
First Author: Zuzana Orszaghova
Poster
2023 ASCO Genitourinary Cancers Symposium
Peripheral blood immune cell profiling in survivors of testicular germ cell tumors.
First Author: Michal Chovanec
Poster
2022 ASCO Annual Meeting
Adverse health outcomes (AHO) in testis cancer survivors (TCS) following high-dose chemotherapy (HDCT) and autologous stem cell transplant.
First Author: Meagan Elizabeth Miller